Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2790820rdf:typepubmed:Citationlld:pubmed
pubmed-article:2790820lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:2790820lifeskim:mentionsumls-concept:C0016030lld:lifeskim
pubmed-article:2790820lifeskim:mentionsumls-concept:C0012854lld:lifeskim
pubmed-article:2790820lifeskim:mentionsumls-concept:C0038734lld:lifeskim
pubmed-article:2790820lifeskim:mentionsumls-concept:C0044093lld:lifeskim
pubmed-article:2790820pubmed:issue21lld:pubmed
pubmed-article:2790820pubmed:dateCreated1989-11-20lld:pubmed
pubmed-article:2790820pubmed:abstractTextMicromolar concentrations of fecapentaene-12, a mutagen found in human feces, decrease survival measured as colony-forming efficiency and membrane integrity of cultured human fibroblasts. Fecapentaene-12 also decreases the content of cellular free low-molecular-weight thiols including glutathione. Fecapentaene-12 reacts directly with glutathione by causing both decreased levels of free thiol and some concomitant formation of oxidized glutathione, indicating that thiol depletion is a result of both alkylation and oxidative reactions. Exposure of cells to 2 or 5 microM fecapentaene-12 causes significant amounts of DNA-interstrand cross-links and DNA-single strand breaks, respectively, whereas exposure to a higher concentration of fecapentaene-12, i.e., 10 microM, also causes significant DNA-protein cross-links. Results from the reaction of fecapentaene-12 with isolated plasmid DNA parallel the cellular pattern of DNA damage; primarily interstrand cross-links and strand breaks occur also in plasmid DNA. Taken together, these studies show that fecapentaene-12 is a potent cytotoxic and genotoxic agent which can react with cellular thiols and cause several types of DNA damage.lld:pubmed
pubmed-article:2790820pubmed:languageenglld:pubmed
pubmed-article:2790820pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2790820pubmed:citationSubsetIMlld:pubmed
pubmed-article:2790820pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2790820pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2790820pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2790820pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2790820pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2790820pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2790820pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2790820pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2790820pubmed:statusMEDLINElld:pubmed
pubmed-article:2790820pubmed:monthNovlld:pubmed
pubmed-article:2790820pubmed:issn0008-5472lld:pubmed
pubmed-article:2790820pubmed:authorpubmed-author:GrafströmR...lld:pubmed
pubmed-article:2790820pubmed:authorpubmed-author:SundqvistKKlld:pubmed
pubmed-article:2790820pubmed:authorpubmed-author:HarrisC CCClld:pubmed
pubmed-article:2790820pubmed:authorpubmed-author:KakefudaTTlld:pubmed
pubmed-article:2790820pubmed:authorpubmed-author:DypbuktJ MJMlld:pubmed
pubmed-article:2790820pubmed:authorpubmed-author:PlummerS MSMlld:pubmed
pubmed-article:2790820pubmed:authorpubmed-author:EdmanC CCClld:pubmed
pubmed-article:2790820pubmed:issnTypePrintlld:pubmed
pubmed-article:2790820pubmed:day1lld:pubmed
pubmed-article:2790820pubmed:volume49lld:pubmed
pubmed-article:2790820pubmed:ownerNLMlld:pubmed
pubmed-article:2790820pubmed:authorsCompleteYlld:pubmed
pubmed-article:2790820pubmed:pagination6058-63lld:pubmed
pubmed-article:2790820pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2790820pubmed:meshHeadingpubmed-meshheading:2790820-...lld:pubmed
pubmed-article:2790820pubmed:meshHeadingpubmed-meshheading:2790820-...lld:pubmed
pubmed-article:2790820pubmed:meshHeadingpubmed-meshheading:2790820-...lld:pubmed
pubmed-article:2790820pubmed:meshHeadingpubmed-meshheading:2790820-...lld:pubmed
pubmed-article:2790820pubmed:meshHeadingpubmed-meshheading:2790820-...lld:pubmed
pubmed-article:2790820pubmed:meshHeadingpubmed-meshheading:2790820-...lld:pubmed
pubmed-article:2790820pubmed:meshHeadingpubmed-meshheading:2790820-...lld:pubmed
pubmed-article:2790820pubmed:meshHeadingpubmed-meshheading:2790820-...lld:pubmed
pubmed-article:2790820pubmed:meshHeadingpubmed-meshheading:2790820-...lld:pubmed
pubmed-article:2790820pubmed:meshHeadingpubmed-meshheading:2790820-...lld:pubmed
pubmed-article:2790820pubmed:meshHeadingpubmed-meshheading:2790820-...lld:pubmed
pubmed-article:2790820pubmed:meshHeadingpubmed-meshheading:2790820-...lld:pubmed
pubmed-article:2790820pubmed:meshHeadingpubmed-meshheading:2790820-...lld:pubmed
pubmed-article:2790820pubmed:meshHeadingpubmed-meshheading:2790820-...lld:pubmed
pubmed-article:2790820pubmed:meshHeadingpubmed-meshheading:2790820-...lld:pubmed
pubmed-article:2790820pubmed:meshHeadingpubmed-meshheading:2790820-...lld:pubmed
pubmed-article:2790820pubmed:year1989lld:pubmed
pubmed-article:2790820pubmed:articleTitleReactivity of fecapentaene-12 toward thiols, DNA, and these constituents in human fibroblasts.lld:pubmed
pubmed-article:2790820pubmed:affiliationDepartment of Toxicology, Karolinska Institutet, Stockholm, Sweden.lld:pubmed
pubmed-article:2790820pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2790820pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed